ProfileGDS4459 / ENSG00000204245
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 25% 32% 13% 23% 28% 14% 18% 14% 7% 14% 9% 15% 16% 65% 14% 57% 11% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.5725
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.8532
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.5413
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.6123
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.5428
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.9314
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.8718
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.6514
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.057
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.7214
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.579
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.6115
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.8716
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9465
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.6114
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.6557
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.9311